✦ LIBER ✦

Tissue factor pathway inhibitor release is specific for heparin and low molecular weight heparins. Implications in the management of coronary syndromes

✍ Scribed by D. Hoppensteadt; J. Fareed; J. Amiral; W. Jeske; J.M. Walenga; B. Lewis; D. Wetzel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative Effects of Unfractionated He

✍ YouFu Li; Miguel Rodriquez; Frederick A. Spencer; Richard C. Becker 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 309 KB

Rebound activation of coagulation after

✍ John-Bjarne Hansen; Trine Naalsund; Per Morten Sandset; Birgit Svensson 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Rebound activation of coagulation after

✍ John-Bjarne Hansen; Trine Naalsund; Per Morten Sandset; Birgit Svensson 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Low Molecular Weight Heparin and Unfract

✍ Mai-Trang Le Nguyen; Frederick A. Spencer 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 176 KB

Differential Effects of Low Molecular We

✍ John-Bjarne Hansen; Per Morten Sandset 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 74 KB

A contemporary assessment of low-molecul

✍ Eric J. Topol 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 119 KB